Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
  1. 4 Open-market buy Chief Financial Officer bought 4,167 shares at $3.60 ($15,001)
  2. 4 Open-market buy Director bought 4,167 shares at $3.60 ($15,001)
  3. 4 Open-market buy Director bought 2,083 shares at $3.60 ($7,499)
  4. 4 Open-market buy Director bought 4,167 shares at $3.60 ($15,001)
  5. 4 Open-market buy CEO bought 6,700 shares at $3.60 ($24,120)
  6. 4 Open-market buy Director bought 10,000 shares at $2.12 ($21,200)
  7. 4 Open-market buy Chief Financial Officer bought 9,500 shares at $2.10 ($19,950)
  8. 4 Open-market buy CEO bought 5,000 shares at $2.12 ($10,600)
  9. 4 Open-market buy Chief Executive Officer bought 2,500 shares at $2.20 ($5,500)
  10. 4 Other acquisition Director acquired 74 shares (other)
  11. 4 Other acquisition Chief Executive Officer acquired 176 shares (other)
  12. 4 Other acquisition Chief Financial Officer acquired 211 shares (other)
  13. 4 Other acquisition Director acquired 528 shares (other)
  14. 4 Other acquisition Director acquired 71 shares (other)
  15. 4 Other acquisition Chief Scientific Officer acquired 169 shares (other)
  16. 4 Other acquisition Director acquired 282 shares (other)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Conversion Chief Scientific Officer acquired 125,000 shares (conversion)

Page 11 of 16 · 308 filings